4: Statement of changes in beneficial ownership of securities-Officer Bhat Laxminarayan
4: Statement of changes in beneficial ownership of securities-Officer Narayan Prabhu
SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Parag Saxena(16.9%),Vedanta Partners, LLC(14.5%), etc.
SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Laxminarayan Bhat(8.6%)
SC 13G: Statement of acquisition of beneficial ownership by individuals-Millennium Management LLC(5.2%),Millennium Group Management LLC(5.2%), etc.
SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Parag Saxena(18.5%),Vedanta Partners, LLC(15.9%), etc.
Reviva Pharmaceuticals | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Laxminarayan Bhat(10.2%)
Reviva Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-TANG CAPITAL PARTNERS, LP(9.99%),TANG CAPITAL MANAGEMENT, LLC(9.99%), etc.
Reviva Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-Armistice Capital, LLC(6.32%),Steven Boyd(6.32%)
Reviva Pharmaceuticals | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Parag Saxena(19.9%),Vedanta Partners, LLC(19.4%), etc.
Reviva Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director SAXENA PARAG
Reviva Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Funtleyder Leslie D.
Reviva Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Margolin Richard A
Reviva Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Patel Purav
Reviva Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director SAXENA PARAG
Reviva Pharmaceuticals | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Laxminarayan Bhat(13.5%)
Reviva Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Bhat Laxminarayan
Reviva Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Chief Financial Officer Narayan Prabhu
Reviva Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-TANG CAPITAL PARTNERS, LP(9.99%),TANG CAPITAL MANAGEMENT, LLC(9.99%), etc.
Reviva Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities
No Data
No Data